Process for preparing cyclosporin A

Details Process for preparing cyclosporin A Process for preparing cyclosporin A

1997-06-16

1999-02-23

Shah, Mukund J.

Organic compounds -- part of the class 532-570 series

Organic compounds

Unsubstituted hydrocarbyl chain between the ring and the -c-...

540450, 540451, 435 711, 435 713, 530317, 530321, C12P 2104, C07D25900, C07D25700

Patent

active

058745726

DESCRIPTION:

BRIEF SUMMARY
TECHNICAL FIELD

The present invention relates to a novel process for the preparation of cyclosporin A represented by following structural formula(I). ##STR1##
Cyclosporin A represented by the above structural formula is a cyclic peptide of molecular weight 1202, molecular formula C.sub.62 H.sub.111 N.sub.11 O.sub.12, consisting of eleven(11) amino acids, and obtained from a culture fluid of Tolypocladium inflatum, a strain producing cyclosporin A. There are twenty five(25) derivatives of cyclosporin A dependent upon
Chemical name of cyclosporin A is nobutyryl-N-methyl-glycyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-ala nyl-O-alanyl-N-methyl-L-leucyl-N-methyl-L-leucyl-N-methyl-L-valyl!. Showing very strong immunosuppressive effect, cyclosporin A has been used for suppressing rejection symptoms and treating auto-immune diseases. Also, it is known to have antifungal, insecticidal and anti-inflammatory effect


BACKGROUND ART

As prior arts concerning the process for preparing cyclosporin A, methods using fermentation by Cylindrocarpon lucidum and Tolypocladium inflatum are disclosed in GB Patent 1,491,509 and U.S. Pat. No. 4,117,118, and U.S. Pat. No. 4,215,199. Also, various methods to recover cyclosporin A from the culture fluid are disclosed in these patents.
In the above-mentioned patents, a process comprising the steps of extracting mycellium isolated from the culture fluid with a solvent, and then recovering the product by successively using chromatography media such as sephadex, aluminum oxide and silica gel has been used as a process for recovering cyclosporin A from the culture fluid. In accordance with these processes, solvent is added to mycellium as isolated solid obtained by filtering the culture fluid; the mixture is extracted by solvent by means of centrifugal extracter; the resultant extract is pretreated with water or hexane or the like; and then the product is purified through chromatography media such as sephadex, aluminum oxide and silica gel, etc. to obtain cyclosporin A. However, the procedure is complicated because two or three types of chromatography media including sephadex should be used after extracting the mycellium as isolated solid obtained by filtering the culture fluid with solvent. Besides, the processes may cause problems of process economics and environmental pollution because each eluting solvent shoud be used for each chromatography procedure.
Thus, in order to overcome the complexity of the processes and lighten the economic burden, various methods for purifying cyclosporin A have been studied.
For example, according to the teachings of U.S. Pat. No. 5,256,547 and European Patent 507,968 A1, mycellium as isolated solid obtained by filtering the culture fluid is dried and then extracted with a solvent to obtain crude cyclosporin A; the product is pretreated without washing with water or the like, and purified by means of chromatography using aluminum oxide and silica gel avoiding the use of expensive sephadex to obtain cyclosporin A. In addition, according to the teachings of U.S. Pat. No. 5,156,960, the culture fluid is extracted by directly adding solvent, the extract is transferred to a solvent having higher solubility and dried over a drying agent such as anhydrous magnesium sulfate, and the resultant product is purified by chromatography through sephadex and silica gel etc. to obtain cyclosporin A.
Although the art described in U.S. Pat. No. 5,256,547 has advantages in that content of pigment has been reduced by virtue of the solvent extraction and the process has been simplified in the course of solvent pretreatment and chromatography, it also has disadvantage in that an extra process for drying the mycellium should be performed. On the other hand, the art described in U.S. Pat. No. 5,156,960 has an advantage in that solvent extraction is carried out directly from the culture fluid by simply adding a solvent instead of solvent extraction from mycellium separated from the culture fluid after filtration, and the processes through chromatography media are performe

REFERENCES:
patent: 4117118 (1978-09-01), Harri et al.
patent: 4215199 (1980-07-01), Harri et al.
patent: 5156960 (1992-10-01), Jekkel nee Bokany et al.
patent: 5256547 (1993-10-01), Rudat et al.

Affiliated with

Also associated with

Rating

Process for preparing cyclosporin A does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Process for preparing cyclosporin A, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Process for preparing cyclosporin A will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-308436